Searchable abstracts of presentations at key conferences in endocrinology

ea0090p149 | Pituitary and Neuroendocrinology | ECE2023

Is a 20% decrease in free T4 (fT4) levels a reliable marker of secondary hypothyroidism in patients with non-functioning pituitary macroadenoma (NFPA)?

McLaren David , Mitchell Ellen , Z Safdar Nawaz , Gibbons Stephen , D Murray Robert

Background: Central hypothyroidism can be difficult to diagnose as TSH values often reside within the normal range. The Endocrine Society clinical guideline for hormone replacement in hypopituitarism suggests levothyroxine is indicated for treatment of secondary hypothyroidism where fT4 levels decrease by ≥20%. To determine the reliability of this biochemical marker of secondary hypothyroidism we evaluated evolution of TFTs over time within a cohort of NFPA.<p class=...

ea0073aep842 | Late Breaking | ECE2021

The first comprehensive study of the clinical response of a cohort of acromegalic patients with somatostatin responsive headache

Sonia Kaniuka-Jakubowska , J Levy Miles , Pal Aparna , Abeyaratne Dayakshi , Drake William , Kyriakakis Nikolaos , D Murray Robert , M Orme Steve , Gohil Shailesh , Brook Antonia , Leese Graham , Márta Korbonits , Wass John

It is known that acromegaly may be associated with headache as a significant co-morbidity. Amongst all acromegaly headache patients, there is a unique group with specific types of severe headache that fail to improve despite acromegaly therapy and are resistant to conventional analgesics, however, immediately respond to subcutaneous short-acting (SA) somatostatin analogue (SSA) treatment. We have surveyed 8 tertiary specialist UK centres and identified 18 patients (6 females) ...

ea0090p288 | Adrenal and Cardiovascular Endocrinology | ECE2023

Symptoms and Steroid Dose Adjustments Associated with the SARS-CoV-2 Vaccine in Patients with Adrenal Insufficiency

McLaren David , Crowe Grace , Cassidy Christine , Rasool Irum , elsabbagh mohamed , Eyadeh Ahmad , Poe Poe Han Htwe Nang , Gerrard Melinda , Ward Emma , Kassim Saifuddin , Abbas Afroze , Al-Qaissi Ahmed , M Orme Steve , Seejore Khyatisha , Kyriakakis Nikolaos , Maguire Deirdre , Lynch Julie , D Murray Robert

Background: Following vaccination for SARS-CoV-2 a significant proportion of individuals experience moderate to severe symptoms. In patients with adrenal insufficiency (AI) this has been reported to translate in to need for increased glucocorticoids and incipient or frank adrenal crises. We assessed occurrence of symptoms, need for glucocorticoid dose adjustment and crises in a large cohort of patients with AI following vaccination for SARS-CoV-2.Methods...